packageTislelizumab

tislelizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tislelizumab is a monoclonal antibody that blocks PD-1 and is used to treat several cancers, including esophageal, lung, nasopharyngeal, and stomach cancers. It is an approved medicine, with one product currently authorised in the European Union, though another EU product has been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q28209583 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tislelizumab
ATC codes:L01FF09
DrugBank:DB14922
Wikidata:Q28209583

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown